Watch Omniscope in action.
Omniscope Cofounder & CEO Vijay Vaswani discusses the power of AI in biotechnology at Google Cloud Summit Madrid 2025.
Computational Biologist Ana Mendizabal presents Omniscope's poster for Isokinetic Conference 2025: Inflammation, Immune Age, and Adaptation Dynamics in Football Players.
Chief Scientific Officer & Cofounder Dr. Holger Heyn presents Omniscope's poster for Isokinetic Conference 2025: Inflammation, Immune Age, and Adaptation Dynamics in Football Players.
CEO & Cofounder Vijay Vaswani presents Omniscope's poster for Isokinetic Conference 2025: Inflammation, Immune Age, and Adaptation Dynamics in Football Players.
Join together with Barça Innovation Hub (FCB) and Omniscope the future of Sports Science in this webinar hosted by GSMA Foundry. Discover how precision immunology is unlocking new strategies to train smarter, recover faster, and minimize injury, enhancing your overall performance.
CEO and Cofounder Vijay Vaswani discusses Omniscope's AI and immune system sequencing technology, highlighting their application to optimize athlete performance. He emphasizes the platform's ability to deliver real-time insights that can revolutionize healthcare and sports science, as showcased at Mobile World Congress 2025.
The objective of Omniscope for the EPIVINF project is to test the hypothesis that epigenetic control mechanisms, especially DNA methylation processes that govern the expression of host proteins involved in antiviral immunity to HIV and SARS-CoV-2, play a decisive role in the outcome of vaccination for these pathogens.
At the World Vaccine Congress in Barcelona, Prof. Dr. Holger Heyn and Vijay Vaswani from Omniscope shared insights into how AI and immune profiling accelerate vaccine innovation. Their work emphasizes the importance of understanding immune system responses at a cellular level to develop next-generation vaccines and diagnostics.
